Archer Materials Ltd
Archer Materials Limited is a quantum technology company building advanced semiconductor devices for quantum computing, quantum sensing, and medical diagnostics.
The business
Archer Materials Limited is a quantum technology company building advanced semiconductor devices for quantum computing, quantum sensing, and medical diagnostics. The Company principal activities include technology research and development of the carbon nano onion quantum material (12CQ Project), tunnelling magnetoresistance (TMR) sensor project and graphene-based lab-on-a-chip biosensing chip (biochip) and utilizing semiconductor technology development infrastructure and facilities, research, and development to support technology research and development. The Company is focused on developing its biochip technology, including identifying and developing testing for blood potassium levels, for its first target of hypo- and hyperkalemia detection in chronic kidney disease (CKD) patients. Its biochip marks an inflection point in diagnostics, enabling fast, accurate, and low-cost digital testing.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Australia’s Semiconductor Future: Inside the Semiconductor Australia 2025 Conference
Small Caps readers can now access an exclusive 20% ticket discount via our website banner. Australia’s semiconductor sector is heating up, and the upcoming Semiconductor Australia 2025 Conference is set to showcase the nation’s brightest deep-tech innovators, cutting-edge research, and the investors driving the next wave of advanced manufacturing. Hosted in Sydney, the event brings together global […]
Archer Materials Advances Quantum Tech with Cryogenic TMR Sensor Demonstration
Semiconductor company Archer Materials (ASX: AXE) has completed the demonstration of highly-sensitive magnetic field measurements at cryogenic temperatures using its tunnel magnetoresistance (TMR) sensor technology. The work is part of the company’s 12CQ quantum project focused on developing a carbon-based quantum bit (qubit) semiconductor chip with high bandwidth and low power consumption to replace traditional […]
Archer Materials partners with Paragraf to accelerate development of potassium-sensing Biochip device
Archer Materials (ASX: AXE) has signed a $450,000 deal with UK-based graphene electronics company Paragraf to develop its Biochip potassium-sensing device for in-home testing of chronic kidney disease. The six-month project will accelerate technical progress towards meeting the blood potassium sensing target product profile using a graphene field-effect transistor (gFET). Both companies will leverage their […]
Archer Materials and Hylid Diagnostics partner to develop at-home potassium test for kidney disease
Archer Materials (ASX: AXE) has signed an agreement with Canadian medical device company Hylid Diagnostics to develop a potassium measurement product for at-home testing of chronic kidney disease. The partnership will combine Archer’s Biochip potassium-sensing technology with Hylid’s blood haemolysis sensor technology to develop a prototype at-home testing device that meets stringent accuracy requirements for […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.